Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05014984 · ClinicalTrials.gov registry record · NA

WOOP VA: Promoting Weight Management in Primary Care

A NA study of Obesity, sponsored by VA Office of Research and Development.

Active
Registry status
NA
Development phase
405
Enrollment target
1
Study location

NCT05014984: Active NA study of Obesity, sponsored by VA Office of Research and Development.

NCT05014984 is a NA study of Obesity that is active but no longer recruiting, run by VA Office of Research and Development. The registered enrollment target is 405 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT05014984, a NA study of Obesity, is active but no longer recruiting, sponsored by VA Office of Research and Development.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
405 participants
Enrollment target
1
Study location

Study Summary

Approximately 40% of Veterans have obesity and are at increased risk for cardiometabolic disease. Intensive lifestyle-based weight management programs can lead to clinically significant ( 5%) weight loss. The VA's MOVE! program is effective for promoting weight loss and behavior change for those who attend. Unfortunately, MOVE! has low enrollment and high attrition due to several obstacles including low motivation. Mental Contrasting with Implementation Intentions (MCII) is an innovative strategy developed over 20 years of research that uses imagery to increase motivation for behavior change. MCII can be implemented in primary care settings using an easy to teach technique called "WOOP" (Wish, Outcome, Obstacle, Plan) that Veterans then use regularly on their own with the help of paper-based tools or the WOOP app. The research team will evaluate the efficacy and implementation of MCII when combined with telephone-delivered MOVE! vs. telephone-delivered MOVE! alone to enhance weight management outcomes for Veterans in primary care.

Primary Outcome

The research team will measure weight using a standardized protocol, taking the average of 2 weights in pounds, rounded to the nearest 0.1lb.

Conditions Studied

Interventions

  • BEHAVIORAL mental contrasting with implementation intentions
  • BEHAVIORAL telephone-delivered, telehealth-delivered, and or in-person MOVE! or TeleMOVE!
  • BEHAVIORAL Information About Diet, Physical Activity, and Weight Management (Baseline Visit - 10 minutes): All
  • BEHAVIORAL Telephone MCII Check-ins (30 minutes at 3 days, 4 weeks, and 2 months after baseline visit)

Study Locations (1)

New York

  • VA NY Harbor Healthcare System, New York, NY - New York

Trial Details

FieldValue
Enrollment Target 405 participants
Start Date 2022-02-15
Est. Completion 2026-02-27
Phase NA
VA Office of Research and Development

1,668 total trials

What the registry record for NCT05014984 still lists

NCT05014984 is an interventional study that assigns participants to a tested intervention. The registered 405 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (51% lower).

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 4 interventions - of which mental contrasting with implementation intentions is the first listed.

NCT05014984 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT05014984 about?

NCT05014984 is a clinical study titled "WOOP VA: Promoting Weight Management in Primary Care". Approximately 40% of Veterans have obesity and are at increased risk for cardiometabolic disease. Intensive lifestyle-based weight management programs can lead to clinically significant ( 5%) weight loss. The VA's MOVE! program is effective for promoting weight loss and behavior change for those who...

What is the current status of trial NCT05014984?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 405 participants. The study started on 2022-02-15. Estimated completion is 2026-02-27.

What conditions does trial NCT05014984 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT05014984?

The interventions under investigation include: mental contrasting with implementation intentions (BEHAVIORAL), telephone-delivered, telehealth-delivered, and or in-person MOVE! or TeleMOVE! (BEHAVIORAL), Information About Diet, Physical Activity, and Weight Management (Baseline Visit - 10 minutes): All (BEHAVIORAL), Telephone MCII Check-ins (30 minutes at 3 days, 4 weeks, and 2 months after baseline visit) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05014984?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05014984 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05014984's enrollment target sits among peer trials

405 168th of 1053 higher than 886 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05576350 · 405 participants · NA

    TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk

  • NCT07066657 · 405 participants · Phase 1

    A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors

  • NCT06223360 · 406 participants · Phase 2

    A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)

  • NCT06411769 · 406 participants · NA

    Evidence-based Intervention to Improve Walking Engagement in El Paso, Texas

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05014984, the US trial registry maintained by the National Library of Medicine. NCT05014984 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.